CB203V Animal Cell Culture Technology for the Production of Biologics 4.0 credits
Protein drugs or biopharmaceuticals are taking an increasing part among therapeutic drugs world-wide. Furthermore, a large majority of these are produced from animal cell cultivation based processes. This course gives the fundaments of animal cell cultivation for the production of protein drugs in the pharmaceutical industry, and how these processes are developed, for which practical application is given through simulation software.
The course will be given in April-May 2024
Choose semester and course offering
Choose semester and course offering to see current information and more about the course, such as course syllabus, study period, and application information.
Application
For course offering
Spring 2024 Start 18 Mar 2024 single courses students
Application code
20068
Content and learning outcomes
Course contents
Intended learning outcomes
Literature and preparations
Specific prerequisites
Recommended prerequisites
Equipment
Literature
Examination and completion
If the course is discontinued, students may request to be examined during the following two academic years.
Grading scale
Examination
- LAB1 - Laboratory using computer simulation, 2.0 credits, grading scale: A, B, C, D, E, FX, F
- TEN1 - Written exam, 2.0 credits, grading scale: A, B, C, D, E, FX, F
Based on recommendation from KTH’s coordinator for disabilities, the examiner will decide how to adapt an examination for students with documented disability.
The examiner may apply another examination format when re-examining individual students.
Opportunity to complete the requirements via supplementary examination
Opportunity to raise an approved grade via renewed examination
Examiner
Ethical approach
- All members of a group are responsible for the group's work.
- In any assessment, every student shall honestly disclose any help received and sources used.
- In an oral assessment, every student shall be able to present and answer questions about the entire assignment and solution.